SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-045967
Filing Date
2019-08-14
Accepted
2019-08-14 17:29:09
Documents
78
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a19-10380_110q.htm 10-Q 1214106
2 EX-31.1 a19-10380_1ex31d1.htm EX-31.1 12547
3 EX-31.2 a19-10380_1ex31d2.htm EX-31.2 12033
4 EX-32.1 a19-10380_1ex32d1.htm EX-32.1 5361
5 EX-32.2 a19-10380_1ex32d2.htm EX-32.2 4904
  Complete submission text file 0001104659-19-045967.txt   7054789

Data Files

Seq Description Document Type Size
6 EX-101.INS hepa-20190630.xml EX-101.INS 1536898
7 EX-101.SCH hepa-20190630.xsd EX-101.SCH 58693
8 EX-101.CAL hepa-20190630_cal.xml EX-101.CAL 47162
9 EX-101.LAB hepa-20190630_lab.xml EX-101.LAB 534619
10 EX-101.PRE hepa-20190630_pre.xml EX-101.PRE 441611
11 EX-101.DEF hepa-20190630_def.xml EX-101.DEF 286634
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36856 | Film No.: 191027750
SIC: 2834 Pharmaceutical Preparations